Tudor Arvinte

2.7k total citations
60 papers, 2.1k citations indexed

About

Tudor Arvinte is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Tudor Arvinte has authored 60 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Physiology. Recurrent topics in Tudor Arvinte's work include Protein purification and stability (25 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Tudor Arvinte is often cited by papers focused on Protein purification and stability (25 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Tudor Arvinte collaborates with scholars based in Switzerland, United Kingdom and United States. Tudor Arvinte's co-authors include Robert Gurny, Martinus A.H. Capelle, Amelia Cudd, A.F. Drake, Barthélemy Demeule, Ueli Aebi, Joerg Kistler, Claire Goldsbury, Garth J. S. Cooper and Hans P. Merkle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Tudor Arvinte

60 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tudor Arvinte Switzerland 26 1.5k 432 394 278 269 60 2.1k
James V. Staros United States 28 2.0k 1.3× 267 0.6× 565 1.4× 145 0.5× 252 0.9× 59 3.3k
Michael Wright United Kingdom 25 1.1k 0.7× 125 0.3× 214 0.5× 167 0.6× 228 0.8× 80 2.0k
Quet F. Ahkong United Kingdom 27 1.4k 1.0× 357 0.8× 169 0.4× 236 0.8× 315 1.2× 43 2.1k
Carlos H. Villa United States 28 906 0.6× 379 0.9× 321 0.8× 722 2.6× 1.0k 3.8× 54 2.6k
Carston R. Wagner United States 36 2.6k 1.7× 108 0.3× 300 0.8× 323 1.2× 251 0.9× 129 3.8k
Gustavo Helguera United States 25 1.4k 0.9× 139 0.3× 333 0.8× 711 2.6× 518 1.9× 45 2.8k
Andrew J. S. Jones United States 26 1.7k 1.1× 128 0.3× 559 1.4× 302 1.1× 201 0.7× 67 2.8k
Sukhvinder S. Bansal United Kingdom 29 726 0.5× 115 0.3× 211 0.5× 175 0.6× 215 0.8× 82 2.2k
Sampathkumar Krishnan United States 17 2.0k 1.4× 142 0.3× 879 2.2× 81 0.3× 282 1.0× 18 2.5k
Zhiwen Zhang China 25 2.1k 1.4× 84 0.2× 287 0.7× 222 0.8× 283 1.1× 91 3.0k

Countries citing papers authored by Tudor Arvinte

Since Specialization
Citations

This map shows the geographic impact of Tudor Arvinte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tudor Arvinte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tudor Arvinte more than expected).

Fields of papers citing papers by Tudor Arvinte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tudor Arvinte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tudor Arvinte. The network helps show where Tudor Arvinte may publish in the future.

Co-authorship network of co-authors of Tudor Arvinte

This figure shows the co-authorship network connecting the top 25 collaborators of Tudor Arvinte. A scholar is included among the top collaborators of Tudor Arvinte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tudor Arvinte. Tudor Arvinte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arvinte, Tudor, et al.. (2023). Aggregation of human plasma and of human blood induced in vitro by pegfilgrastim originator formulation buffer and pegfilgrastim products. European Journal of Pharmaceutics and Biopharmaceutics. 193. 158–174. 1 indexed citations
2.
Arvinte, Tudor, et al.. (2019). Part 1: Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions: Comparison of originator with a biosimilar candidate. Journal of Pharmaceutical and Biomedical Analysis. 175. 112742–112742. 8 indexed citations
3.
4.
Arvinte, Tudor, et al.. (2013). Aggregation of biopharmaceuticals in human plasma and human serum. mAbs. 5(3). 491–500. 33 indexed citations
5.
Peters, Bas, Martinus A.H. Capelle, Tudor Arvinte, & E.M.W. van de Garde. (2013). Validation of an automated method for compounding monoclonal antibody patient doses. mAbs. 5(1). 162–170. 19 indexed citations
6.
Larmour, Iain A., et al.. (2012). Ultraviolet Resonance Raman spectroscopy used to study formulations of salmon calcitonin, a starch–peptide conjugate and TGF-β3. European Journal of Pharmaceutics and Biopharmaceutics. 81(2). 392–398. 3 indexed citations
7.
Capelle, Martinus A.H., et al.. (2011). Tryptophan-mPEGs: Novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylation. European Journal of Pharmaceutics and Biopharmaceutics. 79(3). 646–657. 24 indexed citations
8.
Bell, Steven E. J., et al.. (2010). Oxidized Recombinant Human Growth Hormone That Maintains Conformational Integrity. Journal of Pharmaceutical Sciences. 100(1). 110–122. 14 indexed citations
9.
Capelle, Martinus A.H. & Tudor Arvinte. (2008). High-throughput formulation screening of therapeutic proteins. Drug Discovery Today Technologies. 5(2-3). e71–e79. 19 indexed citations
10.
Bocharov, Eduard V., Konstantin V. Pavlov, Marcel J. J. Blommers, Tudor Arvinte, & Alexander S. Arseniev. (2008). Modulation of the Bioactive Conformation of Transforming Growth Factor β: Possible Implications of Cation Binding for Biological Function. Topics in current chemistry. 273. 155–181. 2 indexed citations
11.
Capelle, Martinus A.H., Robert Gurny, & Tudor Arvinte. (2007). High throughput methods to characterize protein permeation and release. International Journal of Pharmaceutics. 350(1-2). 272–278. 2 indexed citations
12.
Demeule, Barthélemy, M. Jayne Lawrence, Alex F. Drake, Robert Gurny, & Tudor Arvinte. (2006). Characterization of protein aggregation: The case of a therapeutic immunoglobulin. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(1). 146–153. 74 indexed citations
13.
Demeule, Barthélemy, Robert Gurny, & Tudor Arvinte. (2006). Detection and characterization of protein aggregates by fluorescence microscopy. International Journal of Pharmaceutics. 329(1-2). 37–45. 118 indexed citations
14.
Capelle, Martinus A.H., Robert Gurny, & Tudor Arvinte. (2006). High throughput screening of protein formulation stability: Practical considerations. European Journal of Pharmaceutics and Biopharmaceutics. 65(2). 131–148. 102 indexed citations
15.
Vosbeck, K., et al.. (2002). Transforming growth factor β-3 crystals as reservoirs for slow release of active TGF-β3. Journal of Controlled Release. 78(1-3). 25–34. 22 indexed citations
16.
Steffen, Thomas, et al.. (2001). Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery. European Spine Journal. 10(0). S132–S140. 73 indexed citations
17.
Arvinte, Tudor, et al.. (2000). Formulation of sustained release aqueous Zn–hirudin suspensions. European Journal of Pharmaceutical Sciences. 11(1). 33–41. 11 indexed citations
18.
Aebi, Ueli, Markus Häner, René Hermann, et al.. (1995). Architecture and Polymorphism of Fibrillar Supramolecular Assemblies Produced by in Vitro Aggregation of Human Calcitonin. Journal of Structural Biology. 115(1). 1–15. 141 indexed citations
19.
Arvinte, Tudor, Barbara Schulz, Amelia Cudd, & C. Nicolau. (1989). Low-pH association of proteins with the membranes of intact red blood cells. I. Exogenous glycophorin and the CD4 molecule. Biochimica et Biophysica Acta (BBA) - Biomembranes. 981(1). 51–60. 19 indexed citations
20.
Cudd, Amelia, Tudor Arvinte, Barbara Schulz, & Claude Nicolau. (1989). Dextran protection of erythrocytes from low‐pH‐induced hemolysis. FEBS Letters. 250(2). 293–296. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James V. Staros Breakdown of academic impact, for papers by Michael Wright Breakdown of academic impact, for papers by Quet F. Ahkong Breakdown of academic impact, for papers by Carlos H. Villa Breakdown of academic impact, for papers by Carston R. Wagner Breakdown of academic impact, for papers by Gustavo Helguera Breakdown of academic impact, for papers by Andrew J. S. Jones Breakdown of academic impact, for papers by Sukhvinder S. Bansal Breakdown of academic impact, for papers by Sampathkumar Krishnan Breakdown of academic impact, for papers by Zhiwen Zhang
Rankless by CCL
2026